Translational Research on Synergy of PD-1 Checkpoint Blockade and Oncolytic Measles Virotherapy

被引：0
|
作者：
Veinalde, Ruta [1 ,2 ]
Pidelaserra-Marti, Gemma [1 ,2 ]
Heidbuechel, Johannes P. W. [1 ,2 ]
Kang, Na [1 ,2 ]
Abate-Daga, Daniel [3 ]
Ball, Claudia R. [4 ,5 ]
Ungerechts, Guy [1 ,2 ]
Engeland, Christine E. [1 ,2 ]
机构：
[1] Natl Ctr Tumor Dis, Heidelberg, Germany
[2] German Canc Res Ctr, Heidelberg, Germany
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Natl Ctr Tumor Dis, Dresden, Germany
[5] German Canc Res Ctr, Dresden, Germany
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
252
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [41] Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
    Lipson, Evan J.
    Lilo, Mohammed T.
    Ogurtsova, Aleksandra
    Esandrio, Jessica
    Xu, Haiying
    Brothers, Patricia
    Schollenberger, Megan
    Sharfman, William H.
    Taube, Janis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [42] Translational research for predictive biomarkers and novel cancer immunotherapies beyond PD-1/PD-L1 blockade therapies
    Togashi, Yousuke
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Enhancement of immune checkpoint PD-1 blockade efficacy in ovarian cancer
    Drakes, Maureen
    Mehrotra, Swati
    Potkul, Ronald
    Liu, Yueying
    Stack, M. Sharon
    Stiff, Patrick
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Genomic biomarkers in relation to PD-1 checkpoint blockade response.
    Seiwert, Tanguy Y.
    Cristescu, Razvan
    Mogg, Robin
    Ayers, Mark
    Albright, Andrew
    Sher, Xinwei
    Liu, Xiaoqiao
    Nebozhyn, Michael
    Zhang, Chunsheng
    Lunceford, Jared
    Joe, Andrew K.
    Cheng, Jonathan D.
    Webber, Andrea L.
    Ibrahim, Nageatte
    Plimack, Elizabeth R.
    Ott, Patrick Alexander
    Ribas, Antoni
    McClanahan, Terrill
    Loboda, Andrey
    Kaufman, David Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [45] Relapsing Polychondritis following PD-1 Blockade by an Immune Checkpoint Inhibitor
    Mutoh, Tomoyuki
    Chikamatsu, Sonoko
    Sasaki, Takatsuna
    Seino, Hiroto
    Sakamoto, Kazuhiro
    Kudo, Masataka
    JMA JOURNAL, 2023, 6 (04): : 552 - 555
  • [46] Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
    Ou, Huilin
    Chen, Keda
    Chen, Linfang
    Wu, Hongcheng
    BMC GENOMIC DATA, 2022, 23 (01):
  • [47] Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
    Zamarin, Dmitriy
    Holmgaard, Rikke B.
    Subudhi, Sumit K.
    Park, Joon Seok
    Mansour, Mena
    Palese, Peter
    Merghoub, Taha
    Wolchok, Jedd D.
    Allison, James P.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (226)
  • [48] PD-1 checkpoint blockade is an emerging treatment for Merkel cell carcinoma
    Cassler, N. M.
    Brownell, I.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (01) : 18 - 18
  • [49] Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
    Huilin Ou
    Keda Chen
    Linfang Chen
    Hongcheng Wu
    BMC Genomic Data, 23
  • [50] Shifting the balance of power? The combination of oncolytic virotherapy and immune checkpoint blockade for glioblastoma treatment
    Lawler, Sean E.
    NEURO-ONCOLOGY, 2017, 19 (04) : 463 - 465
12345